Immutep (IMMP) Accumulated Depreciation (2015 - 2025)
Immutep's (IMMP) quarterly Accumulated Depreciation came in at -$502294.7 in Q4 2025, down 8.67% on a YoY basis from -$549991.4 in Q4 2024, and down 8.67% quarter-over-quarter from -$462210.6 in Q4 2024.
Powered by 
Analysis
Immutep (IMMP) Accumulated Depreciation (2015 - 2025) Analysis & Trends
Immutep (IMMP) has reported Accumulated Depreciation for 3 consecutive years, with -$502294.7 the latest figure, recorded in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | Immutep | 52.57 Mn | 52.57 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -502,294.73 |
| Dec 31, 2024 | -462,210.64 |
| Dec 31, 2015 | -144,704.00 |